Indolicidin is a 13-residue cationic, antimicrobial peptide-amide isolated from the cytoplasmic granules of bovine neutrophils. The unique composition of indolicidin distinguishes it from ␣-helical and ␤-structured cationic peptides, because five of indolicidin's 13 residues are tryptophans: H-Ile-Leu-Pro-Trp-Lys-Trp-Pro-TrpTrp-Pro-Trp-Arg-Arg-NH 2 . Solid phase synthesis of indolicidin gave rise to a minor byproduct that possessed unusual fluorescence and UV absorbance properties compared with authentic indolicidin. The byproduct was purified by combined ion exchange and reversed phase high pressure liquid chromatography steps and was shown be identical to authentic indolicidin in its microbicidal activity against Staphylococcus aureus, Escherichia coli, Candida albicans, and Cryptococcus neoformans. Mass analysis of the byproduct revealed a 2-atomic mass unit reduction compared with indolicidin, suggesting the deprotonation of two indole side chains to form an intrachain ␦ 1 ,␦ 1 -ditryptophan derivative. We confirmed the nature of the cross-linked byproduct, termed X-indolicidin, by absorbance and fluorescence spectroscopy, peptide mapping, and sequence analysis. Edman degradation revealed that Trp-6 and Trp-9 were covalently cross-linked. Compared with indolicidin, X-indolicidin was partially resistant to digestion with trypsin and chymotrypsin, suggesting that the ditryptophan stabilizes a subset of molecular conformations that are protease resistant but that are absent in the native structure.
Antimicrobial proteins and peptides play a central role in immune defense in the lower phyla and are potent effector molecules that contribute to innate immunity in animals (1) (2) (3) (4) . Indolicidin, a member of the cathelicidin protein family (5) , is a cationic, 13-residue antimicrobial peptide that was isolated from the cytoplasmic granules of bovine neutrophils (6) . It has a unique composition that consists of five tryptophans, three prolines, and three basic amino acid residues (two arginines and a lysine), and its carboxyl terminus is amidated. Indolicidin is microbicidal in vitro against Gram-positive and Gramnegative bacteria (6) , fungi (7), protozoa (8) , and human immunodeficiency virus (HIV-1) (9) . The peptide is also cytolytic for erythrocytes (6) and is cytotoxic to rat and human T lymphocytes (10) . Because of its small size and potent antimicrobial activity, indolicidin has been considered as a possible therapeutic agent. In a liposomal formulation, indolicidin was an effective antifungal agent in a mouse model of systemic aspergillosis (7) .
Indolicidin binds to anionic and neutral lipid vesicles and induces leakage of their contents (11) , properties that are consistent with its proposed amphiphilic topology (12) . Fluorescence studies demonstrated that the peptide localizes to the bilayer interface of phospholipid vesicles, and that the resulting permeabilization is lipid-dependent and is produced by graded leakage in anionic (1-palmitoyl-2-oleoyl phosphatidylglycerol) membranes as opposed to "all-or-none" leakage in zwitterionic (1-palmitoyl-2-oleoyl phosphatidylcholine) membranes (11) . The binding and permeabilization of target cell membranes appear to be the mechanisms underlying the microbicidal and cytotoxic activities of indolicidin (13) .
Here we report the characterization of an indolicidin derivative produced during its solid phase synthesis (14) . The derivative, termed X-indolicidin, was determined to contain a TrpTrp cross-link. X-indolicidin was found to possess microbicidal properties identical to those of native indolicidin, although its mass and spectral characteristics distinguish it from the parent peptide. In addition, the introduction of a specific Trp-Trp cross-link confers proteolytic stability to X-indolicidin, suggesting a novel in vitro mechanism for enhancing protein stability.
EXPERIMENTAL PROCEDURES

Materials-Fmoc-protected
1 amino acids were obtained from PerSeptive Biosystems, N-tosyl-L-phenylalanyl chloromethyl ketone-treated bovine trypsin was purchased from Roche Molecular Biochemicals, and N-tosyl-L-lysyl chloromethyl ketone-treated chymotrypsin was from Fluka. All other reagents were the highest grade commercially available. Buffers were prepared with HPLC grade water.
Peptide Synthesis-Indolicidin was synthesized at 1.0-mmol scale using Fmoc chemistry in an automated Milligen 9050 instrument as described previously in Ref. 14 (Synthetic route I). Briefly, amino acid derivatives were activated in situ with benzotriazolyl N-oxytris(dimethylamino)phosphonium hexafluorophosphate/1-hydroxybenzotriazole in the presence of N-methylmorpholine (1:1:1:2) on 5-(4-Fmoc-aminomethyl-3,5-dimethoxyphenoxy)valeryl acid polyethylene glycol-polystyrene resin. The amino acid-to-resin ratio was 4:1 for each coupling reaction, and double coupling was performed at Ile-1, Leu-2, Trp-6, and Trp-9. Arginine residues were protected with 2,2,5,7,8-pentamethyl-* This work was supported by National Institutes of Health Grant AI22931 and funds from Large Scale Biology, Inc. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** To whom correspondence should be addressed: Dept. of Pathology, College of Medicine, University of California, Irvine, CA 92697-4800. Tel.: 949-824-2350; Fax: 949-824-2346; E-mail: meselste@uci.edu. 1 The abbreviations used are: Fmoc, 9-fluorenylmethyloxycarbonyl; RP, reversed phase; HPLC, high performance liquid chromatography; TFA, trifluoroacetic acid; Boc, tert-butoxycarbonyl; PIPES, piperazine-N,NЈ-bis [2- ethanesulfonic acid] disodium salt; PAGE, polyacrylamide gel electrophoresis; MALDI-TOF MS, matrix-assisted laser desorption ionization-time-of-flight mass spectroscopy; DDQ, 2,3-dichloro-5,6-dicyano-1,4-benzoquinone.
chroman-6-sulfonyl and lysine residues were protected with the tertbutoxycarbonyl group (Boc). The route II synthetic protocol was identical to that described above except that chain assembly was performed at 0.2-mmol scale, and all tryptophan residues were protected with Boc.
Following chain assembly, washed peptide resins were preswollen in dichloromethane for 30 min. 1 g of peptide resin was then incubated with 10 ml of Reagent K (TFA/thioanisole/ethanedithiol/phenol/water, 82.5:5:2.5:5:5) for 4 h at room temperature. Crude preparations were extracted three times with 1:1 30% acetic acid:dichloromethane, and the aqueous phase was diluted 1:3 with water and lyophilized. The predominant peptide product, representing more than 90% of the crude material, was purified by reversed phase (RP) HPLC as described (14) . Peak fractions were concentrated by roto-evaporation and analyzed by analytical RP-HPLC with detection at 220, 280, and 320 nm and by acid-urea polyacrylamide gel electrophoresis (PAGE) (14, 15) .
Isolation of X-indolicidin-Preparative HPLC fractions that had unusually high A 320 /A 280 ratios were further purified by isocratic HPLC on a 0.45 ϫ 20-cm PolySulphoethyl A cation exchange column equibrated in 100 mM NaOAc, pH 5.4, containing 25% acetonitrile. Eluent UV absorbance was monitored at 220, 280, and 320 nm. Peak fractions were further purified by RP-HPLC on a 0.4 ϫ 25-cm Vydac C-18 column equilibrated in 0.1% aqueous TFA, developed by gradient elution (0 -20% in 5 min, 20 -32% in 36 min) using 0.1% TFA in acetonitrile with detection at 220, 280, and 320 nm.
Peptide Characterization-Purified peptides were characterized by analytical RP-HPLC as described in the legend to Fig. 2 . Amino acid analysis of peptide hydrolysates (6 N HCl, 150°C, 2 h) were performed by the AccQ Tag method (16) . Ile, Leu, Lys, and Arg values were used for quantitation. Scanning UV-visible spectrophotometry was performed on a Beckman DU-65 spectrophotometer. Molecular masses were determined by matrix-assisted laser desorption ionization-timeof-flight mass spectroscopy (MALDI-TOF MS) on a PerSeptive Voyager-DE Biospectrometry Workstation using ␣-cyano-4-hydroxycinnamic acid matrix. Fluorescence measurements were performed on an SLM-8100 spectrofluorometer. Protein sequencing was performed on a Hewlett-Packard HP 1005 instrument.
Tryptophan Dimerization and Oxidation-Indolicidin was subjected to sequential acidification and oxidation to induce indole dimerization as described by Stachel et al. (17) . Indolicidin (0.5 mol) was stirred in 100 l of anhydrous TFA for 24 h under N 2 . TFA was removed by evaporation in vacuo, and the dried peptide was oxidized by addition of 1.2 equivalents of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ)/ peptide equivalent in 100 l of 1,4-dioxane. Products were analyzed by analytical RP-HPLC as described above.
Enzymatic Digestion-Indolicidin and X-indolicidin were subjected to trypsin digestion in 100 mM Tris-HCl buffer, pH 8.5, for 18 h at 37°C. The peptide concentration was 50 g/ml, and the peptide-to-enzyme ratio was 10:1 by weight. Digestion with ␣-chymotrypsin was carried out identically except that digestion was performed in 0.1 M N-ethyl morpholine acetate buffer (pH 8.0), and the peptide-to-enzyme ratio was 50:1 by weight. Digestion products generated after 10, 30, 60, 90, and 360 min and 18 h were purified by RP-HPLC, and peak samples were characterized by MALDI-TOF MS.
Antimicrobial Assays-Escherichia coli ML35, Staphylococcus aureus 207A, Cryptococcus neoformans 271A, and Candida albicans 16820 were grown to mid-log phase in trypticase soy broth for bacteria or Sabouraud dextrose broth for fungi. Cells were pelleted from growth media, washed, and resuspended in 10 mM PIPES buffer, pH 7.4. Agar diffusion assays were performed according to Lehrer et al. (18) . In brief, 9-cm 2 agar plates (1% agarose buffered with 10 mM PIPES, pH 7.4) were seeded with 10 6 target organisms. 5 l of peptide solution (10 -300 g/ml in 0.01% acetic acid) was loaded into wells formed with a cork borer. After 2 h of incubation at 37°C, the plate was overlaid with molten (42°C) 1% agarose containing 6% (w/v) trypticase soy broth or Sabouraud dextrose broth. Antimicrobial potency was determined by measuring zones of clearing after 18 -48 h of incubation at 37°C.
FIG. 1. Spectral properties of indolicidin and X-indolicidin.
A, UV-visible absorbance spectrum of indolicidin synthesized by using nonprotected tryptophans (I) and protected tryptophans (II), and purified X-indolicidin (X) recorded in 0.01% acetic acid. The concentrations of indolicidin (I and II) and X-indolicidin were 25 and 30.3 M, respectively. B, technical fluorescence excitation spectrum of indolicidin and X-indolicidin in methanol collected for 400 nm emission. I, indolicidin synthesized by route I; N, natural indolicidin; II, indolicidin synthesized by route II.
FIG. 2. HPLC and acid-urea PAGE analysis of indolicidin and X-indolicidin.
Analytical RP-HPLC of indolicidin (A) and X-indolicidin (B) using a Vydac C-18 column, 0.1% aqueous TFA with a 1%/min linear gradient of acetonitrile to 60% was performed (see "Experimental Procedures") with detection at 220, 280, and 320 nm. C, acid-urea PAGE of 3 g of indolicidin (Ind) or X-indolicidin (X) on a 12.5% acrylamide gel stained with formalin-Coomassie Blue.
FIG. 3.
Mapping of the ditryptophan cross-link in X-indolicidin by Edman degradation. 4-nmol samples of indolicidin (q) and Xindolicidin (E) were subjected to quantitative Edman sequencing. The yield of tryptophan in each cycle is plotted as peak area corresponding to phenylthiohydantoin-Trp. Tryptophan yields at cycles 4, 5, 8, 9, and 11 in indolicidin and 4, 8, and 11 in X-indolicidin (marked with plus signs) fall on lines corresponding to repetitive sequencing yields of 78% (indolicidin) and 72% (X-indolicidin). Tryptophan yields at steps 6 and 9 in X-indolicidin were no higher than background.
Peptide microbicidal activities were determined by incubating 2 ϫ 10 6 organisms/ml with 1-30 g/ml peptide in 10 mM PIPES buffer, pH 7.4, at 37°C (15) . After incubation for 30 min (bacteria), 60 min (C. albicans), or 4 h (C. neoformans), the suspensions were plated on trypticase soy broth (bacteria) or Sabouraud dextrose broth (fungi) agar plates. Killing was determined by colony counts after 18 -48 h of incubation at 37°C.
RESULTS
Isolation and Characterization of X-indolicidin-Indolicidin
was separately synthesized using unprotected (route I) (14) and Boc-protected (route II) tryptophan. Purification of the major product obtained by both procedures yielded peptide that was Ն98% pure by RP-HPLC based on peak aborbances measured at 220 and 280 nm. The average masses (MH ϩ values of the material in the main HPLC peak) of both preparations (1906.8, route I; 1907.2, route II) were in excellent agreement with the theoretical value (1907.33). However, fluorescence spectroscopy demonstrated that the peptide obtained via route I synthesis had unusual absorbance and fluorescence spectra not found in the natural peptide or in the synthetic peptide produced via route II. As shown in Fig. 1A , the absorbance spectrum of route I-derived peptide exhibited a local maximum at 325 nm that was lacking in peptide produced by route II. A marked difference was also noted in the fluoroscence properties of the two preparations. Even when excited in the mean band of tryptophan absorbance, route I peptide exhibited a red-shifted fluorescence not consistent with unmodified tryptophan (not shown). The existence of additional spectroscopic species became even more apparent from inspection of technical (uncorrected) excitation spectra collected at the red edge of the emission band at 400 nm (Fig. 1B) . Route I peptide clearly exhibited an additional major component centered at 325 nm, whereas natural indolicidin and route II peptide exhibit no fluorescence excitation, as expected for the tryptophan chromophore. Based on RP-HPLC peak size measured at 220 nm, we estimated that the abnormally fluorescent byproduct, termed X-indolicidin, represented 1.8% of the indolicidin obtained by the RP-HPLC method previously described (14) .
To more fully characterize X-indolicidin, we devised an ion exchange method for its purification. Isocratic fractionation on a cation exchange column (see "Experimental Procedures") provided base-line separation of X-indolicidin from indolicidin.
FIG. 4. Proteolytic digestion of indolicidin and X-indolicidin.
HPLC profiles of ␣-chymotryptic digestion products of indolicidin (A) and X-indolicidin (B) obtained at varied intervals. Fragment sequences were assigned to HPLC peaks based on data obtained by MALDI-TOF mass spectrometry (Table I) . C, percentage of digested indolicidin (q) and X-indolicidin (E) after chymotryptic digestion. D, the extent of trypsin digestion of indolicidin (q) and X-indolicidin (E) was estimated as in A and B. The fractional digestion of the Lys-5-Trp-6 bond was calculated from the quantity of the ILPWK fragment produced by trypsin treatment at each time point. After a RP-HPLC desalting step, purified indolicidin and Xindolicidin were further analyzed. As shown in Fig. 2 , X-indolicidin eluted 1.6 min earlier than indolicidin on analytical RP-HPLC. Moreover, the absorbance at 320 nm, barely detectable in indolicidin, was high in X-indolicidin. This is in agreement with the high A 320 absorbance of purified X-indolicidin revealed in its spectral profile (Fig. 1A) . X-indolicidin also migrated slower than indolicidin in acid-urea PAGE. Because two peptides possess the same ϩ4 charge at pH 2.5, the retardation of X-indolicidin suggests that its geometry and/or flexibility differs substantially from that of indolicidin under the conditions of electrophoresis (5 M urea, 5% acetic acid).
Amino acid analysis of indolicidin and X-indolicidin gave identical values. However, the masses of the two peptides differed. The average mass of the indolicidin molecular ion was 1907.2 Da (theoretical 1907.33 Da) and X-indolicidin was 1905.0 Da. The 2-atomic mass unit difference suggested that two fewer hydrogen atoms were present in X-indolicidin compared with indolicidin. When excited at 320 nm, X-indolicidin gave fluorescence spectra with two closely overlapping peaks with apparent maxima at 370 and 385 nm (not shown) closely resembling that of an extended ring structure produced by intrachain cross-linking of tryptophan residues. The spectra were also very similar to those ditryptophan cross-linked peptides described by Van Vranken and co-workers (17) . Thus, we postulated that X-indolicidin is produced by the cross-linking of two tryptophans at their ␦-carbon atoms.
Cross-link Mapping and Protease Stability of X-indolicidin-
The position of the Trp-Trp cross-link in purified X-indolicidin was determined by Edman sequencing. Automated sequencing of indolicidin and X-indolicidin disclosed very similar sequences and repetitive yields for all residues except tryptophans at positions 6 and 9, where the signal for Trp was no higher than background (Fig. 3) . These results indicated that Trp-6 and Trp-9 are covalently bound in X-indolicidin.
Additional studies were conducted to assess the relative protease susceptibilities of indolicidin and X-indolicidin. Time course analyses of chymotryptic and tryptic digests were analyzed by RP-HPLC and MS (Fig. 4) . The sequences of the purified peptides were deduced by MS in combination with the specific cleavage sites occurring at the carboxyl side of tryptophan (chymotrypsin) or lysine and arginine (trypsin). In every case, the masses of the isolated fragments were consistent with the presence of the Trp-6 -Trp-9 cross-link (Table I) .
Compared with indolicidin, X-indolicidin was relatively resistant to proteolysis by chymotrypsin and trypsin. After 6 h of digestion with either protease, no measurable indolicidin remained (Fig. 4) . However, 15% of the X-indolicidin remained intact after 18 h of digestion with chymotrypsin (Fig. 4C) . A similar result was obtained when X-indolicidin was subjected to digestion with trypsin. For purposes of this analysis, we determined the extent of cleavage at the carboxyl terminus of Lys-5, which was proportional to the HPLC peak size of the generated ILPWK pentapeptide. As shown in Fig. 4D , after 6 h only 26.6% of this peptide bond was cleaved in X-indolicidin, whereas the same bond was fully hydrolyzed in indolicidin.
Antimicrobial Activities-To assess their relative antimicro- bial potencies, X-indolicidin and indolicidin were tested for antibacterial and antifungal activity in vitro. In zone-of-inhibition assays (Fig. 5 ) and in microbicidal assays (Fig. 6) , the activities of X-indolicidin and indolicidin were indistinguishable.
Dimerization of Tryptophan Residues in Indolicidin-The formation of intramolecular and/or intermolecular cross-links between tryptophan side chains may be facilitated by sequential treatment with TFA and an oxidizing agent. TFA induces formation of indolyl-indole intermediates that rearomatize when oxidized to form stable fluorescent products (17) . Whereas the A 220 /A 320 ratio of indolicidin is ϳ150 (Figs. 2A and  7A ), this ratio is markedly reduced in cross-linked derivatives (Fig. 2B) . We used the appearance of 320 nm absorbance to estimate the extent of tryptophan modification following treatment of pure peptide with TFA and DDQ (17) . This resulted in the modification of Ͼ98% of the input material (Fig. 7B) . To assess the effect of a standard cleavage/deprotection reagent on the formation of A 320 absorbing material, pure indolicidin was incubated for 4 h in Reagent K with exposure to air and light. As shown in Fig. 7C , these conditions produced a number of indolicidin derivatives that were A 320 absorbing.
DISCUSSION
The dimerization reaction between tryptophans in TFA was first described more than two decades ago (19, 20) . Mannich dimerization of tryptophan side chains occurs upon exposure of tryptophan-containing peptides to strong acids, and the indoylindole moiety is readily rearomatized by photooxidation (23) or treatment with chemical oxidizing agents such as DDQ to form stable ditryptophans (21, 22) . Van Vranken and co-workers (17, 23) have reported acid-promoted cyclization and DDQ oxidation of short peptides containing two tryptophans to be an efficient method for producing fluorescent ␦ 1 ,␦ 1 Ј-ditryptophan compounds.
The reactivity of polypeptide indole groups may complicate the chemical synthesis of tryptophan-containing sequences. In the case of indolicidin, the high proportion of Trp residues increases the likelihood for side reactions that may include oxidative degradation, dimerization, alkylation, and substitution with sulfenyl chlorides, particularly under acidic conditions (24, 25) . Even the use of competitive scavengers did not completely eliminate dimerization, although the use of Boc-Trp facilitated synthesis of indolicidin with very little side product ( Figs. 1 and 2) .
Under relatively mild conditions, indolicidin was altered by the intrachain cross-linking of at least two tryptophan side chains. There are 25 theoretical congeners resulting from one or two intramolecular cross-links of the five tryptophans in indolicidin. However, the predominant cross-linked species isolated in this study, X-indolicidin, is produced by cross-linking Trp-6 and Trp-9. Mapping of this ditryptophan connectivity was achieved by quantitative Edman degradation (Fig. 3) , and the products of chymotryptic and tryptic digestion were consistent with the introduction of this specific covalent modification (Table I) . Because of the unique spectral properties of ditryptophan, X-indolicidin is readily detected by monitoring its absorbance at 320 nm (Fig. 2) or its fluorescence (Fig. 1) .
The fact that X-indolicidin was retarded in acid-urea PAGE (Fig. 2C) suggests that the ditryptophan introduces rigidity into a portion of the backbone in a manner that impedes its migration through the acrylamide matrix. However, the structural alteration that generates X-indolicidin does not produce differences in the microbicidal properties as compared with indolicidin, because the two peptides were equally potent in antimicrobial assays against bacterial and fungal organisms (Figs. 5 and 6) .
In contrast to their antimicrobial equivalence, X-indolicidin and indolicidin were easily distinguished by their relative susceptibilities to proteolysis. Indolicidin was quantitatively digested within 6 h by chymotrypsin or trypsin (Fig. 4) . Moreover, the fraction of X-indolicidin that remained resistant to digestion after 6 h was unchanged after an additional 12 h, indicating that a portion of the peptide was in a conformation that was completely resistant to trypsin and chymotrypsin. However, the fact that a fraction (15% in the chymotryptic, 73% in the tryptic digest) of X-indolicidin remained resistant to the actions of these proteases suggests that the peptide was in some way nonhomogeneous. We speculate that the protease resistant fraction corresponds to peptide in which Pro-7 is "trapped" by cross-linked Trp-6 and Trp-9 in a cis-or transconformation that confers protease resistance to this peptide conformer. Alternatively, one or more X-indolicidin-derived protease inhibitor could be responsible for the apparent resistance of the peptide to trypsin and chymotrypsin.
Recently, Ladokhin et al. (12) reported circular dichroism experiments on indolicidin and several analogs, studies that suggest that the secondary structure of the peptide is characterized by turns. This proposal differs from that proposed by Falla et al. (13) , who concluded that indolicidin forms a polyproline II helix. According to our model in which a VIa type turn predominates the fold (12), the charged residues and the tryptophans are placed on opposite surfaces, an amphipathic conformation predicted to favor partitioning into phospholipid bilayers. Similar amphiphilicity can be observed in models of X-indolicidin. Fig. 8 shows the indolicidin model with cis-Pro-7 from the work of Ladokhin et al. (12) compared with two possible energy-minimized conformations of X-indolicidin with Pro-7 in the cis-or trans-conformations. In each of the molecules, the indole groups are distributed to produce a hydrophobic face on the side opposite that occupied by the amino terminus and the lysine and arginine side chains. The segregation of hydrophobic and charged side chains gives rise to an amphiphilic conformation that is similar in indolicidin and the two X-indolicidin conformers (Fig. 8) . The preservation of the amphiphilic topology may explain the identical antimicrobial properties of indolicidin and the ditryptophan-containing analog.
Chemically induced Trp-Trp cross-links may provide a means for introducing conformational constraints into polypeptides that are similar to disulfide bridges. The modification of indolicidin in this fashion produced an analog that was as microbicidal as the parent peptide but that was more resistant to proteolysis. Although ditryptophan has not been detected in biological systems, its chemical properties may be similar to the widely studied dityrosine cross-links, a post-translational modification that occurs in a wide variety of organisms (26 -28) .
